lysyl-aspartyl-glutamyl-leucine has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Björndahl, M; Cao, R; Cao, Y; Eriksson, A | 1 |
1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Carcinoma, Lewis Lung
Article | Year |
---|---|
Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biological Assay; Carcinoma, Lewis Lung; Chemotaxis; Dimerization; Endoplasmic Reticulum; Endothelial Cells; Female; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Oligopeptides; Placenta Growth Factor; Pregnancy Proteins; Protein Sorting Signals; Recombinant Fusion Proteins; Retroviridae; Sus scrofa; Transduction, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2004 |